Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00283088 · ClinicalTrials.gov registry record · Phase 1

Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke

A Phase 1 study of Stroke, sponsored by University of California, San Diego.

Completed
Registry status
Phase 1
Development phase
130
Enrollment target
7
Study locations

NCT00283088 is a Phase 1 study of Stroke that has completed, run by University of California, San Diego. The registered enrollment target is 130 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 7 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00283088, a Phase 1 study of Stroke, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
Phase 1
Development phase
130 participants
Enrollment target
7
Study locations

Study Summary

The purpose of this trial is to evaluate if it is safe to use tissue plasminogen activator (tPA) within 6 hours of stroke onset when combined with hypothermia.

Conditions Studied

Stroke

Interventions

  • PROCEDURE hypothermia
  • DRUG tissue plasminogen activator

Study Locations (7)

California

  • Stanford Medical Center - Palo Alto
  • University of California San Diego, Thornton Hospital - San Diego
  • Scripps Mercy Hospital - San Diego
  • University of California San Diego, Hillcrest Medical Center - San Diego

Connecticut

  • Hartford Hospital - Hartford

Missouri

  • Saint Louis University Medical Center - St Louis

Texas

  • Herman Memorial Hospital - Houston

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2003-10
Est. Completion 2009-05
Phase Phase 1

Sponsor

University of California, San Diego

775 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00283088

The ClinicalTrials.gov registry entry for NCT00283088 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which hypothermia is the first listed.

NCT00283088 reports 7 study locations spanning 4 distinct geographic areas - top geographies include California, Connecticut, Missouri.

Frequently Asked Questions

What is clinical trial NCT00283088 about?

NCT00283088 is a clinical study titled "Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke". The purpose of this trial is to evaluate if it is safe to use tissue plasminogen activator (tPA) within 6 hours of stroke onset when combined with hypothermia.

What is the current status of trial NCT00283088?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 130 participants. The study started on 2003-10. Estimated completion is 2009-05.

What conditions does trial NCT00283088 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT00283088?

The interventions under investigation include: hypothermia (PROCEDURE), tissue plasminogen activator (DRUG).

Who is sponsoring clinical trial NCT00283088?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00283088 being conducted?

This trial has 7 study locations across California, Connecticut, Missouri, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.